Anti-Borreliella burgdorferi ospB Antibody (SAA2656) from ProteoGenix; catalogue ARO-A23088; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Your ultimate solution for detecting and studying the key protein of Lyme disease.
This highly specific and sensitive antibody has been developed to target the ospB protein of the Borreliella burgdorferi bacterium, the causative agent of Lyme disease. With its exceptional binding affinity and superior performance, it is an essential tool for researchers and clinicians in the field of biotechnology.
The Anti-Borreliella burgdorferi ospB Antibody (SAA2656) is a monoclonal antibody that specifically recognizes the outer surface protein B (ospB) of the Borreliella burgdorferi bacterium. This protein is crucial for the survival and virulence of the bacterium and is considered a major target for the development of diagnostic and therapeutic strategies for Lyme disease.
This antibody is primarily used for the detection and quantification of ospB protein in various sample types, including tissue lysates, cell culture supernatants, and biological fluids. It can also be used for immunohistochemistry and western blotting applications.
The Anti-Borreliella burgdorferi ospB Antibody (SAA2656) has been extensively tested and validated for its performance in various experimental conditions. It has been successfully used in research studies to investigate the role of ospB in the pathogenesis of Lyme disease, as well as in the development of diagnostic assays for the disease.
With its high specificity and sensitivity, this antibody has also been used in clinical settings for the early detection and monitoring of Lyme disease in patients. Its ability to detect ospB in different sample types makes it a valuable tool for both research and diagnostic purposes.
In summary, the Anti-Borreliella burgdorferi ospB Antibody (SAA2656) is a reliable and efficient tool for studying the key protein of Lyme disease. Its exceptional performance and versatility make it an essential component of any biotechnology research or clinical laboratory. Order now and take your Lyme disease research to the next level.
ProteoGenix catalogue number ARO-A23088. For research use only.
Target: ospB; Clonality: Monoclonal Antibody; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| ospB |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
